No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs112802909 |
chr1:47882690-47882691 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs80358194 |
chr1:47882707-47882708 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs12724260 |
chr1:47882761-47882762 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs527783871 |
chr1:47882818-47882819 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs12724403 |
chr1:47882845-47882846 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs12724404 |
chr1:47882846-47882847 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs552420470 |
chr1:47882885-47882886 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs571095192 |
chr1:47882916-47882917 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs538463445 |
chr1:47882926-47882927 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs387906793 |
chr1:47882946-47882947 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs550433635 |
chr1:47883016-47883017 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs386630974 |
chr1:47883019-47883020 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs2820969 |
chr1:47883024-47883025 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs554538370 |
chr1:47883027-47883028 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs572796508 |
chr1:47883153-47883154 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs533861922 |
chr1:47883167-47883168 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs181619150 |
chr1:47883168-47883169 |
Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs528856611 |
chr1:47883269-47883270 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs148144944 |
chr1:47883370-47883371 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs374899294 |
chr1:47883373-47883374 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs373095398 |
chr1:47883376-47883377 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs74074267 |
chr1:47883414-47883415 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs201356601 |
chr1:47883422-47883423 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs78460138 |
chr1:47883462-47883463 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs34173190 |
chr1:47883519-47883520 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs538648854 |
chr1:47883537-47883538 |
Bivalent Enhancer Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs186863282 |
chr1:47883658-47883659 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs568722651 |
chr1:47883709-47883710 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs2291197 |
chr1:47883769-47883770 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs112641036 |
chr1:47883826-47883827 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs79154012 |
chr1:47883910-47883911 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs373128613 |
chr1:47883931-47883932 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs111597986 |
chr1:47883960-47883961 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs573476530 |
chr1:47883978-47883979 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs2291198 |
chr1:47883983-47883984 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs534165098 |
chr1:47884001-47884002 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs546244746 |
chr1:47884025-47884026 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs140076375 |
chr1:47884061-47884062 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs190890095 |
chr1:47884066-47884067 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs552202544 |
chr1:47884071-47884072 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs550370385 |
chr1:47884095-47884096 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs568751570 |
chr1:47884162-47884163 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs529996979 |
chr1:47884228-47884229 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs11211533 |
chr1:47884229-47884230 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
45 |
rs566445100 |
chr1:47884234-47884235 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs75281543 |
chr1:47884259-47884260 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs182022960 |
chr1:47884278-47884279 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs577486110 |
chr1:47884302-47884303 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs570575149 |
chr1:47884352-47884353 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs78893536 |
chr1:47884415-47884416 |
Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|